Provided by Tiger Fintech (Singapore) Pte. Ltd.

Biodesix, Inc.

0.8161
+0.05256.88%
Post-market: 0.89230.0762+9.34%19:51 EDT
Volume:186.23K
Turnover:147.76K
Market Cap:118.72M
PE:-2.46
High:0.8179
Open:0.7700
Low:0.7637
Close:0.7636
Loading ...

Biodesix Q4 EPS $(0.06) Beats $(0.07) Estimate, Sales $20.43M Beat $19.88M Estimate

Benzinga
·
04 Mar

Press Release: Biodesix Announces Fourth Quarter and Fiscal Year 2024 Results

Dow Jones
·
04 Mar

Analysts Offer Insights on Healthcare Companies: MiMedx Group (MDXG), InfuSystem Holdings, Inc. (INFU) and Biodesix (BDSX)

TIPRANKS
·
03 Mar

Biodesix Inc expected to post a loss of 7 cents a share - Earnings Preview

Reuters
·
01 Mar

Biodesix to Present at TD Cowen 45th Annual Health Care Conference

GlobeNewswire
·
26 Feb

Biodesix to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

GlobeNewswire
·
18 Feb

Biodesix sees Q4 revenue $20.4M, consensus $19.82M

TIPRANKS
·
10 Jan

Biodesix Inc: Q4 Revenue Is Estimated to Be $20.4 Mln

THOMSON REUTERS
·
10 Jan

Biodesix Announces Preliminary Fourth Quarter and Full-Year 2024 Results (Unaudited)

GlobeNewswire
·
10 Jan

BDSX Stock Rises After Publication of Study Data for Nodify CDT Test

Zacks
·
08 Jan

Biodesix announces publication of new Nodify CDT clinical validation study

TIPRANKS
·
07 Jan

Biodesix Announces Publication of a New Nodify CDT® Clinical Validation Study

GlobeNewswire
·
07 Jan

Insider Buys Additional US$234k In Biodesix Stock

Simply Wall St.
·
23 Nov 2024

Biodesix (BDSX) Loses -22.98% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Zacks
·
20 Nov 2024

Biodesix Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.
·
02 Nov 2024

Biodesix Inc (BDSX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Operational ...

GuruFocus.com
·
02 Nov 2024